Steven M. Klosk's most recent trade in Lisata Therapeutics Inc was a trade of 15,789 Common Stock done . Disclosure was reported to the exchange on Jan. 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lisata Therapeutics Inc | Steven M. Klosk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 15,789 | 65,359 (0%) | 0% | 0 | Common Stock | |
Bolt Projects Holdings Inc... | Klosk Steven M. | Director | 25 Nov 2024 | 22,500 | 57,500 | - | 0 | Common Stock | ||
Bolt Projects Holdings Inc... | M. Klosk Steven | Director | 25 Nov 2024 | 15,000 | 72,500 | - | 0 | Common Stock | ||
Bolt Projects Holdings Inc... | M. Klosk Steven | Director | 13 Aug 2024 | 35,000 | 35,000 | - | - | Common Stock | ||
Bolt Projects Holdings Inc... | Steven Klosk M. | Director | 13 Aug 2024 | 35,000 | 0 | - | - | Class B Common Stock | ||
Lisata Therapeutics Inc | M. Klosk Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 19,480 | 49,570 (0%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | Steven M. Klosk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 20,000 | 30,090 (0%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | Steven M. Klosk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 65,430 | 151,390 (1%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | Steven M. Klosk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 37,735 | 85,960 (0%) | 0% | 0 | Common Stock |